domperidone has been researched along with pantoprazole in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Berstad, A; Hatlebakk, JG | 1 |
| Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
| Manavalan, R; Muralidharan, C; Sivakumar, T; Valliappan, K | 1 |
| Babinets', LS; Botsiuk, NIe; Halabits'ka, IM; Riabokon', SS | 1 |
| Ali, HRH; El-Wekil, MM; Khashaba, PY | 1 |
| Bhatia, SJ; Biswas, M; Ingawale, S; Koli, PG; Shetty, YC; Singh, KNM | 1 |
1 review(s) available for domperidone and pantoprazole
| Article | Year |
|---|---|
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
11 other study(ies) available for domperidone and pantoprazole
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetonitriles; Analysis of Variance; Anti-Ulcer Agents; Calibration; Capsules; Chromatography, High Pressure Liquid; Decision Making; Domperidone; Dopamine Antagonists; Methanol; Molecular Structure; Pantoprazole; Phosphates; Phosphoric Acids; Potassium Compounds; Reference Standards; Reproducibility of Results; Research Design; Sensitivity and Specificity; Tablets; Water | 2007 |
[Pathogenetic grounds of trophological impact of chronic pancreatitis complex therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amino Acids; Antioxidants; Ascorbic Acid; Catalase; Domperidone; Female; Gastrointestinal Agents; Humans; Hypoproteinemia; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pancreatin; Pancreatitis, Chronic; Pantoprazole; Proton Pump Inhibitors; Superoxide Dismutase; Vitamin A; Vitamins | 2014 |
Simultaneous voltammetric analysis of anti-ulcer and D
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Domperidone; Electrodes; Graphite; Humans; Oxidation-Reduction; Pantoprazole | 2017 |
Prescription pattern & adverse drug reactions of prokinetics.
Topics: Adult; Domperidone; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Male; Middle Aged; Pantoprazole; Prescriptions; Prospective Studies; Tertiary Care Centers | 2019 |